Forbes - Standing out among local shares, Pharming surged 10.67 pct to 3.63 eur on speculation about an upcoming meeting of the European Medicines Evaluation Agency (EMEA), with investors hoping for an EMEA opinion or even approval of Pharming’s lead product

TFN economic and business calendar to Thursday Oct 25
CNBC - EPS forecast 0.89 usd vs 0.84 (before market opens) FRIDAY OCT 19 BENELUX -Dutch Aug consumer spending -Pharming Q3 results -Mecom’s extended offer period for Wegener ends (1300 GMT) EASTERN EUROPE -Poland Sept output

TFN economic and business calendar to Friday Oct 26
CNBC - EPS forecast 0.89 usd vs 0.84 (before market opens) FRIDAY OCT 19 ASIA -Boral Ltd AGM -Macquarie Infrastructure Group AGM -Australia Sept new vehicle sales data BENELUX -Dutch Aug consumer spending -Pharming Q3

Pharming released Rhucin statement after request from AFM market
Forbes - AMSTERDAM (Thomson Financial) - Pharming NV earlier today prematurely released a statement on the completion of Rhucin clinical trials following a request by Dutch market regulator after the Pharming share price suddenly surged more than 10 pct on

Drug firms fight plan to turn in old meds
Oregonian - Here’s the problem: Expired Xanax or codeine-laced cough syrup in your medicine cabinet could reach a child’s hands or end up as part of a teenage “pharming” party. Throw it away, and it could leach out of a landfill. Flush it down the toilet, and it

You do not need permission to link to any of the pages on this site.
PRWeb - Limited copyright is granted for you to use and/or republish any of the press releases on this site for any legitimate media purpose as long as you (i) reference PRWeb as the source; and (ii) use the press release in its entirety as it is presented

Tags: